TP53 and breast cancer: MCF7 and T47D cell lines were used to compare the effect of USP7 with the p53 protein pathway as approximately half of cancer patients carry the mutant p53 protein (Gasco et al., 2002), which has been correlated with poor prognosis in breast cancer patients (Lai et al., 2004).